Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Reverse Split at AGM?
View:
Post by Kusanation on Aug 18, 2020 6:42pm

Reverse Split at AGM?

What do you think the chances are of a reverse split coming on the Aug.20 AGM call? I say this in light of them doing it in hopes to land on NASDAQ in the fall as they have stated that as being one of their goals in the past. I would really like to be back around the .70 range before the RS for our sake. Thoughts?
Comment by MUGMODs on Aug 18, 2020 7:36pm
This post has been removed in accordance with Community Policy
Comment by Inthepez on Aug 18, 2020 7:49pm
Hopefully the run up (and uplift) happens around the FDA approval meeting. MUGs, technically speaking, can they proceed with phase3 if don’t need get FDA approval? I’m confident they will with Stauffer meeting the requirements of the NSAID division. But, in the off chance, they would have to find another country to proceed like Canada or overseas (EMA meeting)?  quote=MUGMODs]The vote is ...more  
Comment by MUGMODs on Aug 18, 2020 8:08pm
This post has been removed in accordance with Community Policy
Comment by Lookingforclues on Aug 18, 2020 8:42pm
As it stands now, the meeting will push out from 2020 to early 2021 and the Phase 3 trial begins in Q2-ish.  Fingers crossed for little further delay. Mugs...how long have you been saying that...Does that mean another year which has 12 months!  
Comment by MasterAlgae on Aug 19, 2020 12:05am
Chance of a RS at the AGM? 0%. Stock needs to be $4 USD to get a NASDAQ listing. We'd need to see ATE north of .60 for X number of days before a 10:1 At today's exchange rate .60 = .46 so a RS would be $4.60 USD - might be cutting it close to the wire even at that price.
Comment by Kusanation on Aug 19, 2020 12:21am
But who is to say they would do a 30x1 at .40 cents?
Comment by MUGMODs on Aug 19, 2020 6:25am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities